Also known as: Elidel; ASM981
Pimecrolimus is a calcineurin inhibitor used as a topical immunomodulator for the treatment of atopic dermatitis (eczema). It inhibits T-cell activation and cytokine release by binding to macrophilin-12, preventing calcineurin activation. Mediocon Inc manufactures Pimecrolimus API at its GMP-certified facility in Aurangabad, Maharashtra, India.
| Parameter | Specification |
|---|---|
| CAS Number | 137071-32-0 |
| Molecular Formula | C43H68N4O11 |
| Molecular Weight | 810.02 g/mol |
| Grade | IP / BP / USP |
| Category | Calcineurin Inhibitor / Immunomodulator |
| Appearance | White to off-white, crystalline powder |
| Solubility | Freely soluble in methanol, slightly soluble in ethanol, practically insoluble in water |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Batch No | PIM/24032026 |
| Mfg Date | MAR 2026 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Pimecrolimus — CAS 137071-32-0 (CAS 137071-32-0) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Pimecrolimus — CAS 137071-32-0 is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance